# Roche Diagnostics invests 3 billion yuan in Suzhou production base expansion

Roche Diagnostics (Suzhou) signed an investment agreement with Suzhou Industrial Park to invest an initial 3 billion yuan in a new project for reagent and instrument production and R&D. The new facility will be built on 55 mu of land and is scheduled to start production in 2028.

- Type: Expansion
- Announced: 2024-08-21
- Where: Suzhou, Jiangsu, China, China
- Value: $420.0M (3.00B CNY)
- Starts operating: 2028
- Status: announced
- Capacity: 55 mu (approx. 3.67 hectares) first phase, total 108 mu (7.2 hectares)
- Products: diagnostic reagents, diagnostic instruments
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Roche Diagnostics](https://endata.com/companies/29985.md)

## Sources

- [finance.sina.com.cn](https://finance.sina.com.cn/roll/2024-08-23/doc-inckrpne2716176.shtml), 2024-08-23: "现有生产设施、物流和关键生产线即将达到产能极限。鉴于此，我们需要扩充产能，以满足下一个阶段的市场需求，这也为未来研发活动的扩展提供了灵活性。"
- [news.qq.com](https://news.qq.com/rain/a/20240823A06G0G00), 2024-08-23: "8月21日，罗氏诊断产品（苏州）有限公司与苏州工业园区管委会签署苏州基地新投资项目协议，首期投资30亿人民币，用于罗氏诊断试剂和仪器设备生产研发基地的新项目厂房建设和关键产品组合的本地化生产制造。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.